SJS Investment Consulting’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.12K Buy
29
+14
+93% +$3.68K ﹤0.01% 1168
2026
Q1
$4K Buy
15
+3
+25% +$812 ﹤0.01% 1100
2025
Q4
$3.01K Sell
12
-72
-86% -$19.1K ﹤0.01% 1048
2025
Q3
$24.1K Buy
84
+78
+1,300% +$20.9K ﹤0.01% 492
2025
Q2
$1.58K Sell
6
-6
-50% -$1.46K ﹤0.01% 646
2025
Q1
$2.79K Buy
12
+2
+20% +$485 ﹤0.01% 600
2024
Q4
$2.29K Sell
10
-2
-17% -$459 ﹤0.01% 647
2024
Q3
$2.68K Buy
12
+3
+33% +$659 ﹤0.01% 668
2024
Q2
$1.83K Hold
9
﹤0.01% 763
2024
Q1
$1.97K Sell
9
-1
-10% -$220 ﹤0.01% 760
2023
Q4
$2.27K Sell
10
-2
-17% -$420 ﹤0.01% 611
2023
Q3
$2.41K Sell
12
-2
-14% -$422 ﹤0.01% 563
2023
Q2
$2.9K Sell
14
-3
-18% -$582 ﹤0.01% 470
2023
Q1
$3.44K Buy
17
+3
+21% +$617 ﹤0.01% 447
2022
Q4
$2.83K Hold
14
﹤0.01% 492
2022
Q3
$3K Buy
+14
New +$2.87K ﹤0.01% 392
2022
Q1
$1K Buy
+2
New +$470 ﹤0.01% 592

Other funds holding LH

SJS Investment Consulting's LH Position: Q2 2026 in Review

SJS Investment Consulting increased its Labcorp (LH) stake by 93% in Q2 2026, buying an estimated $3.68K and bringing the position to 29 shares worth $8.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1168.

SJS Investment Consulting first reported a position in LH in Q1 2022 and has held it in 17 quarters since. The position peaked at $24.1K in Q3 2025. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • SJS Investment Consulting held 29 shares of Labcorp worth $8.12K as of Q2 2026.
  • SJS Investment Consulting bought 14 Labcorp shares in Q2 2026, an estimated $3.68K.
  • Labcorp made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1168 holding.
  • SJS Investment Consulting first reported a position in Labcorp in Q1 2022 and has held it in 17 quarters since.
  • SJS Investment Consulting's Labcorp position peaked at $24.1K in Q3 2025.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.